報價延遲最少15分鐘:2026/01/09 22:05 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.42 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.47/-0.53
|
|
企業價值
33.74M
|
| 資產負債 |
|
每股賬面淨值
0.60
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain. |
